title: Olmesartan: sprue-like enteropathy.
abstract: Olmesartan exposes patients to the risk of sometimes serious chronic intestinal disorders with diarrhoea (sprue-like enteropathy). As of late 2013, this adverse effect has not been reported with other angiotensin II receptor blockers (ARBs).
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001284:Atrophy; D002908:Chronic Disease; D003967:Diarrhea / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007422:Intestines / Q000187:drug effects / Q000473:pathology; D008286:Malabsorption Syndromes / Q000139:chemically induced* / Q000145:classification / Q000175:diagnosis; D012307:Risk Factors; D013777:Tetrazoles / Q000009:adverse effects*; D015431:Weight Loss
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan